CHEN Ming, et al. Clinical effect of moxonidine made in China in the treatment of patients with essential hypertension. [J]. Journal of Chongqing Medical University (4):471-472(2002)
CHEN Ming, et al. Clinical effect of moxonidine made in China in the treatment of patients with essential hypertension. [J]. Journal of Chongqing Medical University (4):471-472(2002)DOI:
Clinical effect of moxonidine made in China in the treatment of patients with essential hypertension
Objective: To evaluate the clinical effect of moxonidine(made in Chengdu
China) in the treatment of patients with essential hypertension. Methods: 50 patients with essential hypertension were treated with moxonidine for 4 to 6 weeks. Results: After treatment with moxonidine
BP of the patients were reduced significantly by 33/15±9/4mmHg (P<0.01). The total effective rate was 92%. Conclusion: Moxonidine made in China is effective in the treatment of essential hypertension.
Repeated measures-based comparison of patient-reported outcomes for patients with hypertension having different medication regimens and blood pressure levels
Echocardiographic changes in patients with acromegaly with hypertension and abnormal glucose metabolism
Research progress in the diagnosis and treatment of non-eosinophilic asthma
Clinical features and treatment outcome of scrotal abscess: an analysis of 24 cases
Diagnosis and treatment strategies for retroperitoneal vascular leiomyosarcoma
Related Author
Tang Shunding
Zhang Wen
Deng Li
Song Ying
Wang Han
Zhang Xiaoqing
Zhang Ru
Li Haiyan
Related Institution
School of Public Health,Kunming Medical University
Department of Cardiology, Fuwai Yunnan Cardiovascular Hospital
Chronic and Non-communicable Disease Prevention and Control Division,Baoshan Center for Disease Control and Prevention
Department of Ultrasound,The Second Affiliated Hospital of Army Medical University
Department of Endocrinology,The First Affiliated Hospital of Army Medical University